Susa Coffey, MD

Professor

Susa Coffey, MD, HS Clinical Professor, is an attending physician at the UCSF Division of HIV, Infectious Diseases and Global Medicine at SFGH and Lead of the RAPID ART program at SFGH. She also is Editor-in-Chief, UCSF Center for HIV Information and HIV InSite, and Medical Editor, AIDS Education Training Center National Resource Center.

Academic Focus: Dr. Coffey leads the RAPID ART program at SFGH and supports implementation of RAPID ART programs in the United States. She also is the Editor-in-Chief at the UCSF Center for HIV Information and HIV InSite. She develops HIV-related educational and training materials for domestic and international use, using web-based as well as print formats. She also trains medical residents and medical students in the care persons with HIV infection. Her interests include antiretroviral therapy, immediate ART initiation, primary care of persons with HIV/AIDS, and underserved populations.

Publications

  1. Campbell CK, Koester KA, Erguera XA, Moran L, LeTourneau N, Broussard J, Crouch PC, Lynch E, Camp C, Torres S, Schneider J, VanderZanden L, Coffey S, Christopoulos KA. Effective Messages to Reduce Stigma among People Newly Diagnosed with HIV during Rapid ART Initiation. International journal of environmental research and public health 2024. PMID: 39338016


  2. Doshi RK, Hull S, Broun A, Boyani S, Moch D, Visconti AJ, Castel AD, Baral S, Colasanti J, Rodriguez AE, Jones J, Coffey S, Monroe AK. Lessons learned from U.S. rapid antiretroviral therapy initiation programs. International journal of STD & AIDS 2023. PMID: 37461333


  3. Moran L, Koester KA, Le Tourneau N, Coffey S, Moore K, Broussard J, Crouch PC, VanderZanden L, Schneider J, Lynch E, Roman J, Christopoulos KA. The Rapid interaction: a qualitative study of provider approaches to implementing Rapid ART. Implementation science communications 2023. PMID: 37452427


  4. Koester KA, Moran L, LeTourneau N, VanderZanden L, Coffey S, Crouch PC, Broussard J, Schneider J, Christopoulos KA. Essential elements of and challenges to rapid ART implementation: a qualitative study of three programs in the United States. 2022. PMID: 35361148


  5. Johnson KA, Graglia S, Lynch ED, De Mesa J, Antunez E, Torres S, Coffey S, Cohen SE. Concurrent COVID-19 and Acute HIV: A Case Report and Diagnostic Review. 2021. PMID: 34824585


  6. Bacon OML, Coffey SC, Hsu LC, Chin JCS, Havlir DV, Buchbinder SP. Development of a Citywide Rapid Antiretroviral Therapy Initiative in San Francisco. 2021. PMID: 34686290


  7. Christopoulos KA, Erguera XA, VanderZanden L, Campbell C, Green M, Tsuzuki MD, Schneider J, Coffey S, Bacon O, Gandhi M, Koester KA. A Qualitative Study of the Experience of Immediate Antiretroviral Therapy Among Urban Persons With Newly Diagnosed Human Immunodeficiency Virus. 2021. PMID: 34877362


  8. Bacon O, Chin J, Cohen SE, Sachdev D, Coffey S, Scheer S, Hessol NA, Buchbinder S, Havlir DV, Hsu L. Decreased Time from HIV Diagnosis to Care, ART Initiation, and Virologic Suppression during the Citywide RAPID Initiative in San Francisco. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020. PMID: 32449916


  9. Coffey S, Halperin J, Rana AI, Colasanti JA. Rapid Antiretroviral Therapy: Time for a new standard of care. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020. PMID: 32777033


  10. Coffey S, Bacchetti P, Sachdev D, Bacon O, Jones D, Ospina-Norvell C, Torres S, Lynch E, Camp C, Mercer-Slomoff R, Lee S, Christopoulos K, Pilcher C, Hsu L, Jin C, Scheer S, Havlir D, Gandhi M. RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population. AIDS (London, England) 2019. PMID: 30882490


  11. Cohen SE, Sachdev D, Lee SA, Scheer S, Bacon O, Chen MJ, Okochi H, Anderson PL, Kearney MF, Coffey S, Scott H, Grant RM, Havlir D, Gandhi M. Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report. The lancet. HIV 2018. PMID: 30503324


  12. Coffey, S, ed. Guide for HIV/AIDS Clinical Care Guide for HIV/AIDS Clinical Care 2014. PMID:


  13. Coffey S and Volberding PA. Global HIV/AIDS Medicine, 2nd Edition, Volberding PA et al, eds Overview of Antiretroviral Therapy 2012. PMID:


  14. Coffey S, ed. Guide for HIV/AIDS Clinical Care Guide for HIV/AIDS Clinical Care. 2011. PMID:


  15. Coffey, S. Guide for HIV/AIDS Clinical Care Antiretroviral Therapy 2011. PMID:


  16. Coffey, S. Guide for HIV/AIDS Clinical Care Dyslipidemia 2011. PMID:


  17. Ross D and Coffey S, eds. Primary Care of Veterans with HIV Primary Care of Veterans with HIV. 2009. PMID:


  18. Coffey S, editor. Clinical Management of the HIV-Infected Adult Clinical Management of the HIV-Infected Adult. 2006. PMID: